A TRIBUTE TO PAUL GREENGARD (1925-2019)

1. PAUL GREENGARD: A PERSISTENT DESIRE TO COMPREHEND THE BRAIN, AND ALSO TO FIX IT MARC FLAJOLET, THU LAN N-GUYEN, VIJAY KUMAR SIRIPURAM AND YASHODA KRISHNA SUNKARI 2. GIVING NAMES TO THE ACTORS OF SYNAPTIC TRANSMISSION: THE LONG JOURNEY FROM SYNAPTIC VESICLES TO NEURAL PLASTICITY FABIO BENFENATI, MARTIN BAHLER AND FLAVIA VALTORTA 3. CAMP-REGULATED PHOSPHOPROTEINS DARPP-32, ARPP16/19, AND RCS MODULATE STRIATAL SIGNAL TRANSDUCTION THROUGH PROTEIN KINASES AND PHOSPHATASES KYLE R. CHRISTENSEN AND ANGUS C. NAIRN 4. DARPP-32 40 YEARS LATER JEAN-ANTOINE GIRAULT AND ANGUS C. NAIRN 5. EFFECTS OF NICOTINE ON DARPP-32 AND CAMKII SIGNALING RELEVANT TO ADDICTION ANGELA M. LEE AND MARINA R. PICCIOTTO 6. MODULATION OF DENDRITIC SPINES BY PROTEIN PHOSPHATASE-1 JIMCY PLATHOLI AND HUGH C. HEMMINGS JR 7. DECIPHERING CELL-TYPE SPECIFIC SIGNAL TRANSDUCTION IN THE BRAIN: CHALLENGES AND PROMISES JEAN-PIERRE ROUSSARIE AND PATRICIA RODRIGUEZ-RODRIGUEZ 8. DRUG-ACTIVATED CELLS: FROM IMMEDIATE EARLY GENES TO NEURONAL ENSEMBLES IN ADDICTION MARINE SALERY, ARTHUR GODINO AND ERIC J. NESTLER 9. NAPE-SPECIFIC PHOSPHOLIPASE D REGULATES LRRK2 ASSOCIATION WITH NEURONAL MEMBRANES FRANCESCA PALESE, SILVIA PONTIS, NATALIA REALINI AND DANIELE PIOMELLI 10. AMYLOIDOGENIC AND ANTI-AMYLOIDOGENIC PROPERTIES OF PRESENILIN 1 VICTOR BUSTOS, MARIA PULINA AND JOSE LEDO 11. A REVIEW OF THE PHARMACOLOGY AND CLINICAL PROFILE OF LUMATEPERONE FOR THE TREATMENT OF SCHIZOPHRENIA GRETCHEN L SNYDER, KIMBERLY E VANOVER, ROBERT E DAVIS, PENG LI, ALLEN FIENBERG AND SHARON MATES 12. UNITING HOMEOSTATIC PLASTICITY AND EXOSOME BIOLOGY: A REVISION OF THE CONCEPTUAL FRAMEWORK FOR DRUG DISCOVERY IN NEURODEGENERATIVE DISEASES? JAMES K.T. WANG

A TRIBUTE TO PAUL GREENGARD, VOLUME 90, THE LATEST RELEASE IN THE ADVANCES IN PHARMACOLOGY SERIES PRESENTS A VARIETY OF CHAPTERS FROM THE BEST AUTHORS IN THE FIELD, WITH THIS RELEASE PRESENTING A TRIBUTE TO PAUL GREENGARD.